Table 1. Describing a brief synopsis of important features of reported cases.

COVID-19: coronavirus disease 2019

Study	Demographics	Disease onset	Symptoms	Treatment	Outcome
Smith et al. [11]	36-year Afro-American lady, no known psychiatric history	4 days after onset of upper respiratory symptoms (Rhinorrhea and nasal congestion)	Rapidly progressive change in behavior, persecutory delusion, anxiety	Initially treated with olanzapine for 7 days and clonazepam for anxiety.	Complete recovery was noted on Follow up after 1 week from discharge.
Haddad et al. [8]	30-year male from South-east Asia working in Qatar	Body aches and anxiety for 4 days prior to testing positive for COVID-19*.	Paranoid delusions, increased agitation, anxiety, insomnia, and restlessness	Risperidone 1 mg bid and mirtazapine 30mg/day.	Follow up after 2 weeks showed complete resolution of symptoms with the patient being able to return to work.
Anmella et al. [13]	42-year female, physician, no known medical, psychiatric or family history.	2 weeks before caring for patients with suspicion of COVID-19 and psychiatric symptoms.	Delusional ideas of catastrophe regarding the current pandemic situation suspiciousness and delusions of self-reference, surveillance and persecution, with high affective and behavioral involvement	Olanzapine 10 mg	Patient symptoms improved with the olanzapine.